OXYTROL

Product NDC: 0023-6153
11-digit product format: 000236153
Labeler code: 0023
Product ID: 0023-6153_12aace89-ecb2-4706-a0bd-5bd24b8db2ed
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Oxybutynin
Dosage form: PATCH
Route: TRANSDERMAL
Labeler: Allergan, Inc.
Application: NDA021351
Marketing category: NDA
Marketing start: 2003-02-26
Substance: OXYBUTYNIN
Active strength: 3.9 mg/d
Pharmacologic classes: Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021351-002	OXYTROL	OXYBUTYNIN	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL		RLD, RS	2003-02-26

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021351-002	OXYTROL	3.9MG/24HR	FILM, EXTENDED RELEASE / TRANSDERMAL	RLD, RS	2003-02-26	`cb3db0bc1861…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021351-002	6743441	2020-04-26	U-318	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021351-002	7081249	2020-04-26	U-318	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021351-002	7081250	2020-04-26	U-318	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021351-002	7081251	2020-04-26	U-318	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021351-002	7081252	2020-04-26	U-318	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021351-002	7179483	2020-04-26	U-318	Drug substance, Drug product	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	N021351-002	6743441	2020-04-26	U-318	Drug product	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021351-002	7081249	2020-04-26	U-318	Drug product	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021351-002	7081250	2020-04-26	U-318	Drug product	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021351-002	7081251	2020-04-26	U-318	Drug product	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021351-002	7081252	2020-04-26	U-318	Drug product	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021351-002	7179483	2020-04-26	U-318	Drug substance, Drug product	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021351-002	6743441	2020-04-26	U-318	Drug product	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021351-002	7081249	2020-04-26	U-318	Drug product	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021351-002	7081250	2020-04-26	U-318	Drug product	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021351-002	7081251	2020-04-26	U-318	Drug product	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021351-002	7081252	2020-04-26	U-318	Drug product	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021351-002	7179483	2020-04-26	U-318	Drug substance, Drug product	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021351-002	6743441	2020-04-26	U-318	Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021351-002	7081249	2020-04-26	U-318	Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021351-002	7081250	2020-04-26	U-318	Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021351-002	7081251	2020-04-26	U-318	Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021351-002	7081252	2020-04-26	U-318	Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021351-002	7179483	2020-04-26	U-318	Drug substance, Drug product	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021351-002	6743441	2020-04-26	U-318	Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021351-002	7081249	2020-04-26	U-318	Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021351-002	7081250	2020-04-26	U-318	Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021351-002	7081251	2020-04-26	U-318	Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021351-002	7081252	2020-04-26	U-318	Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021351-002	7179483	2020-04-26	U-318	Drug substance, Drug product	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021351-002	6743441	2020-04-26	U-318	Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021351-002	7081249	2020-04-26	U-318	Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021351-002	7081250	2020-04-26	U-318	Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021351-002	7081251	2020-04-26	U-318	Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021351-002	7081252	2020-04-26	U-318	Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021351-002	7179483	2020-04-26	U-318	Drug substance, Drug product	`ea99ee380514…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OXYTROL	OXYBUTYNIN	Allergan, Inc.	20dee37f-1412-44ed-9e8b-f4379ce23eb0	2024-05-29	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021351 application number: NDA021351 ndc (product): 0023-6153

Additional Listing Data#

Finished product: Yes
Brand name base: OXYTROL
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
OXYBUTYNIN	3.9 mg/d

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
K9P6MC7092	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
403799	Internal RxNorm lookup
404448	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
20dee37f-1412-44ed-9e8b-f4379ce23eb0	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
3544f362-07fc-93b1-457b-1fba00be087a	Product name	8	20230316
4daffbf2-44c8-ca46-d284-5db69e1e6ef4	Product name	8	20210525
982338c6-c45c-b6b4-1452-14b01fbdf98d	Product name	2	20180801
054197ba-7ed3-0ddb-321e-dbb51c0fe9b6	Product name	2	20171212
3544f362-07fc-93b1-457b-1fba00be087a	Product name	2	20171212
8b00ae7e-01f2-f83c-632e-edfc23808364	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0023-6153-08	OXYTROL	1 in 1 POUCH	PATCH	1		8
0023-6153-08	OXYTROL	8 in 1 BOX	PATCH	8		8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0023-6153-08	EA - Each	0023-6153	ddbbd75f-4a4c-4909-b3f3-71797afb879f	1	2018-11-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0023-6153	OXYTROL (OXYBUTYNIN) PATCH [ALLERGAN, INC.]	8	Current NDC, Legacy NDC, 2 package rows	20250109_20dee37f-1412-44ed-9e8b-f4379ce23eb0.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
K9P6MC7092	OXYBUTYNIN	5633-20-5	OXYBUTYNIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
403799	oxyBUTYnin 3.9 MG/Day Twice Weekly Transdermal System	PSN	20dee37f-1412-44ed-9e8b-f4379ce23eb0	8
404448	OXYTROL 3.9 MG/Day Twice Weekly Transdermal System	PSN	20dee37f-1412-44ed-9e8b-f4379ce23eb0	8
404448	84 HR oxybutynin 0.162 MG/HR Transdermal System [Oxytrol]	SBD	20dee37f-1412-44ed-9e8b-f4379ce23eb0	8
403799	84 HR oxybutynin 0.162 MG/HR Transdermal System	SCD	20dee37f-1412-44ed-9e8b-f4379ce23eb0	8
404448	84 HR Oxytrol 0.162 MG/HR Transdermal System	SY	20dee37f-1412-44ed-9e8b-f4379ce23eb0	8
403799	oxybutynin 0.162 MG/HR 84 HR Transdermal Patch	SY	20dee37f-1412-44ed-9e8b-f4379ce23eb0	8
403799	oxybutynin 3.9 MG/Day Twice Weekly Transdermal Patch	SY	20dee37f-1412-44ed-9e8b-f4379ce23eb0	8
403799	oxybutynin 3.9 MG/Day Twice Weekly Transdermal System	SY	20dee37f-1412-44ed-9e8b-f4379ce23eb0	8
404448	Oxytrol 3.9 MG/Day Twice Weekly Transdermal Patch	SY	20dee37f-1412-44ed-9e8b-f4379ce23eb0	8
404448	OXYTROL 3.9 MG/Day Twice Weekly Transdermal System	SY	20dee37f-1412-44ed-9e8b-f4379ce23eb0	8

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0023-6153-08	00023615308	8 POUCH in 1 BOX (0023-6153-08) / 1 PATCH in 1 POUCH / 4 d in 1 PATCH	8 pouch	2003-02-26	0000-00-00	No	No	Current